138 related articles for article (PubMed ID: 30257098)
1. Methylation of bone
Shan Y; Wang L; Li G; Shen G; Zhang P; Xu Y
Biochem Cell Biol; 2019 Aug; 97(4):369-374. PubMed ID: 30257098
[TBL] [Abstract][Full Text] [Related]
2. Osterix and RUNX2 are Transcriptional Regulators of Sclerostin in Human Bone.
Pérez-Campo FM; Santurtún A; García-Ibarbia C; Pascual MA; Valero C; Garcés C; Sañudo C; Zarrabeitia MT; Riancho JA
Calcif Tissue Int; 2016 Sep; 99(3):302-9. PubMed ID: 27154028
[TBL] [Abstract][Full Text] [Related]
3. Methylation of bone SOST, its mRNA, and serum sclerostin levels correlate strongly with fracture risk in postmenopausal women.
Reppe S; Noer A; Grimholt RM; Halldórsson BV; Medina-Gomez C; Gautvik VT; Olstad OK; Berg JP; Datta H; Estrada K; Hofman A; Uitterlinden AG; Rivadeneira F; Lyle R; Collas P; Gautvik KM
J Bone Miner Res; 2015 Feb; 30(2):249-56. PubMed ID: 25155887
[TBL] [Abstract][Full Text] [Related]
4. [Expression and regulation of the SOST gene].
Qin LJ; Ding DX; Cui LL; Huang QY
Yi Chuan; 2013 Aug; 35(8):939-47. PubMed ID: 23956082
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation contributes to the regulation of sclerostin expression in human osteocytes.
Delgado-Calle J; Sañudo C; Bolado A; Fernández AF; Arozamena J; Pascual-Carra MA; Rodriguez-Rey JC; Fraga MF; Bonewald L; Riancho JA
J Bone Miner Res; 2012 Apr; 27(4):926-37. PubMed ID: 22162201
[TBL] [Abstract][Full Text] [Related]
6. Silencing of LncRNA-ANCR Promotes the Osteogenesis of Osteoblast Cells in Postmenopausal Osteoporosis via Targeting EZH2 and RUNX2.
Cai N; Li C; Wang F
Yonsei Med J; 2019 Aug; 60(8):751-759. PubMed ID: 31347330
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation regulates sclerostin (SOST) expression in osteoarthritic chondrocytes by bone morphogenetic protein 2 (BMP-2) induced changes in Smads binding affinity to the CpG region of SOST promoter.
Papathanasiou I; Kostopoulou F; Malizos KN; Tsezou A
Arthritis Res Ther; 2015 Jun; 17(1):160. PubMed ID: 26071314
[TBL] [Abstract][Full Text] [Related]
8. Bone Matrix Levels of Dickkopf and Sclerostin are Positively Correlated with Bone Mass and Strength in Postmenopausal Osteoporosis.
Ueland T; Stilgren L; Bollerslev J
Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31197079
[TBL] [Abstract][Full Text] [Related]
9. Sclerostin is a direct target of osteoblast-specific transcription factor osterix.
Yang F; Tang W; So S; de Crombrugghe B; Zhang C
Biochem Biophys Res Commun; 2010 Oct; 400(4):684-8. PubMed ID: 20816666
[TBL] [Abstract][Full Text] [Related]
10. Computational and functional characterization of four SNPs in the SOST locus associated with osteoporosis.
Ye W; Wang Y; Mei B; Hou S; Liu X; Wu G; Qin L; Zhao K; Huang Q
Bone; 2018 Mar; 108():132-144. PubMed ID: 29307778
[TBL] [Abstract][Full Text] [Related]
11. Effects of intermittent parathyroid hormone (PTH) administration on SOST mRNA and protein in rat bone.
Silvestrini G; Ballanti P; Leopizzi M; Sebastiani M; Berni S; Di Vito M; Bonucci E
J Mol Histol; 2007 Aug; 38(4):261-9. PubMed ID: 17549589
[TBL] [Abstract][Full Text] [Related]
12. TIEG and estrogen modulate SOST expression in the murine skeleton.
Subramaniam M; Pitel KS; Bruinsma ES; Monroe DG; Hawse JR
J Cell Physiol; 2018 Apr; 233(4):3540-3551. PubMed ID: 29044507
[TBL] [Abstract][Full Text] [Related]
13. Genetics of Sost/SOST in sclerosteosis and van Buchem disease animal models.
Sebastian A; Loots GG
Metabolism; 2018 Mar; 80():38-47. PubMed ID: 29080811
[TBL] [Abstract][Full Text] [Related]
14. Control of the SOST bone enhancer by PTH using MEF2 transcription factors.
Leupin O; Kramer I; Collette NM; Loots GG; Natt F; Kneissel M; Keller H
J Bone Miner Res; 2007 Dec; 22(12):1957-67. PubMed ID: 17696759
[TBL] [Abstract][Full Text] [Related]
15. Successful induction of sclerostin in human-derived fibroblasts by 4 transcription factors and its regulation by parathyroid hormone, hypoxia, and prostaglandin E2.
Fujiwara M; Kubota T; Wang W; Ohata Y; Miura K; Kitaoka T; Okuzaki D; Namba N; Michigami T; Kitabatake Y; Ozono K
Bone; 2016 Apr; 85():91-8. PubMed ID: 26851122
[TBL] [Abstract][Full Text] [Related]
16. Estrogen Modulates Bone Morphogenetic Protein-Induced Sclerostin Expression Through the Wnt Signaling Pathway.
Kim RY; Yang HJ; Song YM; Kim IS; Hwang SJ
Tissue Eng Part A; 2015 Jul; 21(13-14):2076-88. PubMed ID: 25837159
[TBL] [Abstract][Full Text] [Related]
17. Identification of the disease-causing gene in sclerosteosis--discovery of a novel bone anabolic target?
Balemans W; Van Hul W
J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):139-42. PubMed ID: 15615113
[TBL] [Abstract][Full Text] [Related]
18. Sp7 Transgenic Mice with a Markedly Impaired Lacunocanalicular Network Induced Sost and Reduced Bone Mass by Unloading.
Moriishi T; Ito T; Fukuyama R; Qin X; Komori H; Kaneko H; Matsuo Y; Yoshida N; Komori T
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328592
[TBL] [Abstract][Full Text] [Related]
19. Role of BMPs in the regulation of sclerostin as revealed by an epigenetic modifier of human bone cells.
Delgado-Calle J; Arozamena J; Pérez-López J; Bolado-Carrancio A; Sañudo C; Agudo G; de la Vega R; Alonso MA; Rodríguez-Rey JC; Riancho JA
Mol Cell Endocrinol; 2013 Apr; 369(1-2):27-34. PubMed ID: 23415712
[TBL] [Abstract][Full Text] [Related]
20. Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: a novel mechanism for hormonal control of osteoblastogenesis.
Bellido T; Ali AA; Gubrij I; Plotkin LI; Fu Q; O'Brien CA; Manolagas SC; Jilka RL
Endocrinology; 2005 Nov; 146(11):4577-83. PubMed ID: 16081646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]